The U.S. Patent and Trademark Office has created a new intellectual property platform for patent-related COVID-19 technologies that are available for licensing.
The U.S. Patent and Trademark Office (USPTO) has created a new intellectual property platform for patent-related COVID-19 technologies that are available for licensing. The initial goal of the Patents 4 Partnerships platform is to facilitate the commercialization of new products and technologies that can prevent diagnose, or treat the coronavirus (COVID-19).
“Patents 4 Partnerships is a meeting place that enables patent owners who want to license their IP rights to connect with the individuals and businesses who can turn those rights into solutions for our health and wellbeing,” Andrei Iancu, Director of the USPTO, said in a press statement.
How Patents 4 Partnerships Works
Patents 4 Partnerships is essentially an online database designed to facilitate connections between entities who have technologies and want to make them available for licensing and those who have an interest in and the ability to commercialize the technologies.
For entities who would like to make their inventions available for licensing, the IP Marketplace Platform provides a centralized and easily accessible place to list U.S. patents and patent application publications. Potential licensees can then search the database of available technologies using a variety of parameters, such as keyword, inventor name, assignee, and issue date. For each technology, the platform lists whether the licensing status is currently “available” or “unknown” by the USPTO. The platform also provides a link to sources that include the licensing information for each specific technology.
In light of needs created by the current pandemic, the initial release of the IP Marketplace Platform focuses on listing technologies related to the prevention, diagnosis, and treatment of COVID-19, including personal protective equipment (PPE), disinfectants, ventilators, testing equipment and components thereof. According to the USPTO, the platform may be expanded to additional technologies once the COVID-19 crisis has passed.
The Patents 4 Partnerships Platform currently includes information derived from several sources, including the USPTO, the Federal Laboratory Consortium for Technology Transfer, the AUTM Innovation Marketplace, the National Institutes of Health, the Department of Energy, the National Aeronautics and Space Administration, the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Department of Defense. IP owners are invited to submit additional technologies that they believe are related to the COVID-19 crisis.
Negotiating IP Licenses
As noted by the USPTO, previous or ongoing legal actions, administrative actions, or other causes may affect the legal status of published patent applications or patents listed on the Platform. In addition, transfers of rights, such as assignments and licenses affecting the published patent applications or patents listed on the Patents 4 Partnerships Platform, may not be known to the USPTO and consequently not be reflected on the database.
It is also important to highlight that the USPTO’s Patents for Partnership platform is intended to facilitate connections between licensees and licensors. The negotiation of any transfers or grants of rights for the IP listed on the platform will be conducted by the parties, and their legal counsel, outside the USPTO platform.
When it comes to IP rights, it is essential to work with a knowledgeable attorney who can help you maximize your profits, limit your risks, and protect your legal rights. At Scarinci Hollenbeck, our intellectual property attorneys can help patent owners and potential licensees successfully navigate the patent licensing process.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact me, David Einhorn, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
When to Settle and When to Fight: A Litigator's Framework
Every lawsuit comes with a cost, and knowing when to settle a lawsuit is one of the most consequential decisions a business owner will face. Experienced litigators understand how to minimize cost and obtain certainty for their clients. For many business owners, the decision is viewed almost entirely through a financial lens: What will it cost […]
A Whistleblower Just Filed a Complaint Against Your Company: Here's What to Do Now
Few situations create more uncertainty than learning that an employee has filed a whistleblower complaint. Questions arise immediately: Is the allegation legitimate? Should the employee be placed on leave? Do we need to notify our insurance carrier? Are we now prevented from disciplining the employee if there are unrelated ongoing work related issues? There is […]
Assignment for the Benefit of Creditors: An Alternative to Bankruptcy for Distressed Businesses
When a business reaches the point where it can no longer service its debts or otherwise resolve its liabilities, management is often faced with a difficult question: is a bankruptcy filing necessary or is there another way to perform an orderly liquidation or sale of the business assets? While Chapters 7 and 11 of the […]
Breaking Down New Jersey’s “Mansion” Tax: What Buyers and Sellers Need to Know
For many years, the New Jersey Mansion Tax has been a significant consideration in high-value real estate transactions. Recent legislative changes, however, have substantially altered how the tax operates, including who is responsible for paying it and the amount owed in certain transactions. Whether you are purchasing, selling, or investing in New Jersey real estate, […]
Estate Planning for Digital Assets Under New Jersey Law
As our personal and financial lives increasingly move online, estate planning must evolve to address a new category of property: digital assets. From email accounts and social media profiles to cryptocurrency and cloud-stored business records, these assets often carry both financial and sentimental value. Yet, without proper planning, they can become inaccessible—or even lost—upon incapacity […]
The Role of Representation and Warranty Insurance in M&A Transactions
In today’s mergers and acquisitions market, representation and warranty (R&W) insurance has become a common feature of deal negotiations. Once used primarily in larger transactions, R&W insurance is now frequently incorporated into middle-market deals as buyers and sellers look for efficient ways to allocate risk and close deals. When structured properly, R&W insurance can help […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
